Orphenadrine Citrate
6 NDCs across 4 manufacturers|6 Generic,0 Brand
Orphenadrine Citrate is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Orphenadrine Citrate across 70,000 claims for 40,000 beneficiaries.
Orphenadrine Citrate is available as 6 NDCs from 4 manufacturers (6 generic, 0 brand), with NADAC prices from $0.34 to $0.46 per EA — a 36% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
4
competing in market
Price Spread
$0.34 – $0.46
per EA, 4 of 6 NDCs
7d Activity
avg -0.6% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing ORPHENADRINE CITRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ORPHENADRINE 60 MG/2 ML VIAL | $7.0744 per ML | — |
ORPHENADRINE 60 MG/2 ML VIAL | $5.7097 per ML | +0.12% |
ORPHENADRINE ER 100 MG TABLET | $0.4586 per EA | -0.79% |
ORPHENADRINE ER 100 MG TABLET | $0.4586 per EA | -0.79% |
ORPHENADRINE ER 100 MG TABLET | $0.4586 per EA | -0.79% |
ORPHENADRINE ER 100 MG TABLET | $0.3361 per EA | — |
Frequently Asked Questions
What is Orphenadrine Citrate used to treat?
Orphenadrine Citrate is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.
When did Orphenadrine Citrate become available as a generic?
FDA approved the first generic Orphenadrine Citrate (ANDA) on Jan 1, 1982. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Orphenadrine Citrate?
In 2024, Medicare Part D spent $2 million on Orphenadrine Citrate across 70,000 claims for 40,000 beneficiaries.
How many Orphenadrine Citrate products are on the market?
The Orphenadrine Citrate drug market contains 6 NDCs from 4 manufacturers — 6 generic and 0 brand products.
What is the price range for Orphenadrine Citrate?
NADAC reference prices for Orphenadrine Citrate range from $0.3361 to $0.4586 per EA — a 36% difference between cheapest and most expensive. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Orphenadrine Citrate?
4 manufacturers list Orphenadrine Citrate in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (3), Hikma Pharmaceuticals USA Inc. (1), Sagent Pharmaceuticals (1), Sandoz Inc. (1).
How has the price of Orphenadrine Citrate changed recently?
Over the past 7 days, 1 Orphenadrine Citrate NDC rose and 3 fell, with a market-wide average change of -0.6%.